Health and Healthcare

All Health and Healthcare Articles

Newest first · Page 368

Boston Scientific And Johnson & Johnson: Stents Make A Comeback?

http://www.bloomberg.com/apps/news?pid=20601087&sid=ajZ2lVrqeb2I&refer=homeA study out fo Sweden may help the flagging fortunes of the stent businesses at Boston Scientific (BSX) and Johnsohn & Johnson (JNJ). Several pieces of research had indicated that drug-coated stents could cause…

Douglas A. McIntyre · 19 years ago

IPO FILING: ARYx Therapeutics, Inc. (ARYX, PG)

ARYx THERAPEUTICS, INC. has filed to raise up to $86.25 million in an IPO under the ticker "ARYX" on NASDAQ.  The biotech has secured Morgan Stanley, CIBC World Markets, Jefferies & Co, and Leerink…

Douglas A. McIntyre · 19 years ago

The Ariad Pharmaceuticals Conundrum (ARIA, MRK)

Business Week has run a brief feature article on Ariad Pharmaceuticals (NASDAQ:ARIA) in its "Inside Wall Street" magazine section and noted that the company’s partner Merck (NYSE:MRK), has "deep pockets."  Unfortunately it only spells…

Douglas A. McIntyre · 19 years ago

Xoma Gets A Boost

Biopharmaceutical company Xoma (XOMA) is having its luck day. After its stock traded down as low as $2.24, its shares are up almost 20% today on news that it bacterial cell expression technology to…

Douglas A. McIntyre · 19 years ago

IPO FILING: Precision Therapeutics

Precision Therapeutics is a life sciences company developing and commercializing tests intended to assist physicians in individualizing cancer therapy in an effort to improve treatment outcomes unde the name ChemoFx test.  ChemoFx is a…

Douglas A. McIntyre · 19 years ago

Earnings Preview: Medtronic August 2007 (MDT)

Medtronic (NYSE:MDT) posts earnings after the close on Tuesday, August 21, and First Call estimates are $0.62 EPS on $3.17 Billion in revenues.  The following quarter is looking like estimates are $0.65 EPS and…

Douglas A. McIntyre · 19 years ago

Amgen Moves From Biotech to Big Pharma, With More Baggage

Amgen Inc. (NASDAQ:AMGN) did what Wall Street thought it would in its after-the-bell conference call.  The biotech giant announced layoffs to the tune 12% to 14% of its workforce, which translates to about 2,200…

Douglas A. McIntyre · 19 years ago

Wyeth (WYE): More Bad News

Wyeth’s (WYE) shares are off 10% over the last three months, and trade near their 52-week low. The stock is about to go lower. The company disclosed the receipt of an action letter from…

Douglas A. McIntyre · 19 years ago